[Pubmed] The Risk of Exacerbation of Myasthenia Gravis After COVID-19 Omicron Infection
Posté : 20 oct. 2024 12:00
Brain Behav. 2024 Oct;14(10):e70074. doi: 10.1002/brb3.70074.
ABSTRACT
OBJECTIVE: The aim of this study is to ascertain whether COVID-19 Omicron infection is associated with exacerbations in these myasthenia gravis (MG) patients.
RESULT: In total, 289 MG patients (comprising 60% females, with an average age of 46 ± 15 years) were enrolled. A total of 80.9% of MG patients reported a COVID-19 infection, with the majority experiencing a benign course (88%). MG patients who experienced COVID-19 infection demonstrated a higher likelihood of MG exacerbation, compared to those without the infection (18.8% vs. 7.3%, p = 0.039). In the survival analysis, after adjusting for confounding factors, the hazard ratio (HR) for exacerbation post-infection was found to be 3.38 (95% CI 1.20-9.53, p = 0.021). Compared to the exacerbation rates observed in JTA21, an increase was noted in DTM23 among COVID-19-infected MG patients (4.4% vs. 17.2%, p < 0.001).
CONCLUSION: The COVID-19 is the risk of MG exacerbation.
PMID:39428557 | DOI:10.1002/brb3.70074
Source: https://pubmed.ncbi.nlm.nih.gov/3942855 ... t9+e462414